ID   SH21A_RAT               Reviewed;         126 AA.
AC   B2RZ59;
DT   16-DEC-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-2008, sequence version 1.
DT   24-JAN-2024, entry version 89.
DE   RecName: Full=SH2 domain-containing protein 1A;
GN   Name=Sh2d1a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION IN NTRK2 SIGNALING, AND INTERACTION WITH NTRK1; NTRK2 AND NTRK3.
RX   PubMed=16223723; DOI=10.1074/jbc.m506554200;
RA   Lo K.Y., Chin W.H., Ng Y.P., Cheng A.W., Cheung Z.H., Ip N.Y.;
RT   "SLAM-associated protein as a potential negative regulator in Trk
RT   signaling.";
RL   J. Biol. Chem. 280:41744-41752(2005).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Cytoplasmic adapter regulating receptors of the signaling
CC       lymphocytic activation molecule (SLAM) family such as SLAMF1, CD244,
CC       LY9, CD84, SLAMF6 and SLAMF7. In SLAM signaling seems to cooperate with
CC       SH2D1B/EAT-2. Initially it has been proposed that association with
CC       SLAMF1 prevents SLAMF1 binding to inhibitory effectors including
CC       INPP5D/SHIP1 and PTPN11/SHP-2. However, by simultaneous interactions,
CC       recruits FYN which subsequently phosphorylates and activates SLAMF1.
CC       Positively regulates CD244/2B4- and CD84-mediated natural killer (NK)
CC       cell functions. Can also promote CD48-, SLAMF6 -, LY9-, and SLAMF7-
CC       mediated NK cell activation. In the context of NK cell-mediated
CC       cytotoxicity enhances conjugate formation with target cells (By
CC       similarity). May also regulate the activity of the neurotrophin
CC       receptors NTRK1, NTRK2 and NTRK3 (PubMed:16223723).
CC       {ECO:0000250|UniProtKB:O60880, ECO:0000250|UniProtKB:O88890,
CC       ECO:0000269|PubMed:16223723}.
CC   -!- SUBUNIT: Interacts with CD84, CD244, LY9, SLAMF1 and FYN (By
CC       similarity). Interacts with NTRK1, NTRK2 and NTRK3.
CC       {ECO:0000250|UniProtKB:O88890, ECO:0000269|PubMed:16223723}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O88890}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC167036; AAI67036.1; -; mRNA.
DR   EMBL; CH473991; EDM10890.1; -; Genomic_DNA.
DR   RefSeq; NP_001102783.2; NM_001109313.2.
DR   RefSeq; XP_008771750.1; XM_008773528.2.
DR   AlphaFoldDB; B2RZ59; -.
DR   SMR; B2RZ59; -.
DR   STRING; 10116.ENSRNOP00000008444; -.
DR   iPTMnet; B2RZ59; -.
DR   PhosphoSitePlus; B2RZ59; -.
DR   PaxDb; 10116-ENSRNOP00000008444; -.
DR   Ensembl; ENSRNOT00055025502; ENSRNOP00055020807; ENSRNOG00055014907.
DR   Ensembl; ENSRNOT00060036851; ENSRNOP00060030362; ENSRNOG00060021262.
DR   GeneID; 501502; -.
DR   KEGG; rno:501502; -.
DR   UCSC; RGD:1562408; rat.
DR   AGR; RGD:1562408; -.
DR   CTD; 4068; -.
DR   RGD; 1562408; Sh2d1a.
DR   eggNOG; KOG0565; Eukaryota.
DR   HOGENOM; CLU_125532_1_0_1; -.
DR   InParanoid; B2RZ59; -.
DR   OrthoDB; 3891423at2759; -.
DR   PhylomeDB; B2RZ59; -.
DR   TreeFam; TF343096; -.
DR   PRO; PR:B2RZ59; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   Proteomes; UP000234681; Chromosome x.
DR   Bgee; ENSRNOG00000006263; Expressed in thymus and 11 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0007267; P:cell-cell signaling; IEA:InterPro.
DR   GO; GO:0006968; P:cellular defense response; IEA:InterPro.
DR   GO; GO:0006959; P:humoral immune response; ISO:RGD.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0050776; P:regulation of immune response; ISO:RGD.
DR   CDD; cd10400; SH2_SAP1a; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR017289; SH2_prot_1A.
DR   InterPro; IPR035876; SH2D1A_SH2.
DR   PANTHER; PTHR46051:SF1; IPPC DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR46051; SH2 DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF00017; SH2; 1.
DR   PIRSF; PIRSF037828; SH2_p1A; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   SMART; SM00252; SH2; 1.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Adaptive immunity; Cytoplasm; Immunity; Innate immunity;
KW   Phosphoprotein; Reference proteome; SH2 domain.
FT   CHAIN           1..126
FT                   /note="SH2 domain-containing protein 1A"
FT                   /id="PRO_0000356885"
FT   DOMAIN          6..102
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   REGION          67..92
FT                   /note="Interaction with FYN SH3 domain"
FT                   /evidence="ECO:0000250|UniProtKB:O88890"
FT   REGION          100..126
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         89
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O60880"
FT   MOD_RES         119
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   126 AA;  13992 MW;  79BE17CC42049E6E CRC64;
     MDAVTVYHGK ISREMGEKLL LATGLDGSYL LRDSESVPGV YCLCVLYQGY IYTYRVSQTE
     TGSWSAETAP GVHKRFFRKV KNLISAFQKP DQGIVTPLQY PVEKSSARSP QAPTGRRDSD
     ICLKAP
//
